Clinical trial / 2011
Trial protocol evaluates green tea extract for preventing recurrent colorectal adenomas.
This protocol describes a randomized multicenter trial designed to assess green tea extract against placebo for preventing metachronous colon adenomas. A planned cohort of 2,534 post-polypectomy patients will receive 150 mg epigallocatechin gallate twice daily or placebo for 3 years. The primary endpoints include the incidence, count, and histology of adenomas identified during follow-up colonoscopy.
- Study type
- Randomized controlled trial protocol
- Who was studied
- Planned 2,534 post-polypectomy patients
- What was measured
- Colorectal adenoma recurrence
THE PAPER
Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population.
Stingl JC, Ettrich T, Muche R, Wiedom M, Brockmöller J, Seeringer A, Seufferlein T. BMC Cancer, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.